本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

再鼎医药

20.99
-0.7600-3.49%
成交量:12.75万
成交额:269.92万
市值:23.36亿
市盈率:-10.92
高:21.39
开:21.31
低:20.92
收:21.75
52周最高:44.34
52周最低:20.92
股本:1.11亿
流通股本:1.09亿
量比:0.49
换手率:0.12%
股息:- -
股息率:- -
每股收益(TTM):-1.9229
每股收益(LYR):-2.5984
净资产收益率:-28.97%
总资产收益率:-13.29%
市净率:3.07
市盈率(LYR):-8.08

数据加载中...

2024/06/18

重要事件披露

Form 8-K - Current report
2024/06/11

重要事件披露

Form 8-K - Current report
2024/06/06

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/17

SEC问询函

Form CORRESP - Correspondence